Glaucoma, the second leading cause of blindness globally, affects millions and is projected to reach 111.8 million cases by ...

Could an ordinary carrot improve the treatment of type 2 diabetes? A new study from SDU suggests so. The researchers found that carrots can enhance the body's ability to regulate blood sugar and ...

NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) ("NurExone" or the "Company"), a developer of exosome-based therapies for regenerative medicine, is pleased to announce that it has ...

Artificial intelligence-enabled discovery of a RIPK3 inhibitor with neuroprotective effects in an acute glaucoma mouse model ...

A study published in 2022 revealed a tenuous but plausible link between picking your nose and increasing the risk of ...

In a world where health supplements are increasingly prevalent, finding a product that genuinely supports your well-being can ...

Glaucoma is a progressive eye disorder characterized by fluid buildup inside the eye, causing ocular hypertension. By 2040, ...

At first, I was skeptical, like many of the people I read about in ProNerve6 reviews. However, after reading through multiple ...

Nivolumab is under clinical development by Bristol-Myers Squibb and currently in Phase II for Paranasal Sinus And Nasal Cavity Cancer.

Nivolumab is under clinical development by Bristol-Myers Squibb and currently in Phase II for Squamous Cell Carcinoma.